Thermo Fisher Scientific (TMO) : Old Second National Bank Of Aurora scooped up 75 additional shares in Thermo Fisher Scientific during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Apr 21, 2016. The investment management firm now holds a total of 11,024 shares of Thermo Fisher Scientific which is valued at $1,618,874.Thermo Fisher Scientific makes up approximately 0.76% of Old Second National Bank Of Aurora’s portfolio.
Thermo Fisher Scientific opened for trading at $145.61 and hit $147.7521 on the upside on Wednesday, eventually ending the session at $147.14, with a gain of 1.05% or 1.53 points. The heightened volatility saw the trading volume jump to 14,97,750 shares. Company has a market cap of $58,306 M.
Other Hedge Funds, Including , Advisory Services Network boosted its stake in TMO in the latest quarter, The investment management firm added 152 additional shares and now holds a total of 6,639 shares of Thermo Fisher Scientific which is valued at $974,937. Thermo Fisher Scientific makes up approx 0.26% of Advisory Services Network’s portfolio.Longview Partners (guernsey) Ltd reduced its stake in TMO by selling 123,096 shares or 2.38% in the most recent quarter. The Hedge Fund company now holds 5,056,270 shares of TMO which is valued at $742,513,250. Thermo Fisher Scientific makes up approx 4.83% of Longview Partners (guernsey) Ltd’s portfolio. Bkd Wealth Advisors sold out all of its stake in TMO during the most recent quarter. The investment firm sold 1,444 shares of TMO which is valued $209,871.
On the company’s financial health, Thermo Fisher Scientific reported $2.12 EPS for the quarter, beating the analyst consensus estimate by $ 0.01 according to the earnings call on Jan 28, 2016. Analyst had a consensus of $2.11. The company had revenue of $4652.50 million for the quarter, compared to analysts expectations of $4551.79 million. The company’s revenue was up 3.6% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.99 EPS.
Many Wall Street Analysts have commented on Thermo Fisher Scientific. Company shares were Reiterated by Mizuho on Apr 4, 2016 to “Buy”, Firm has raised the Price Target to $ 160 from a previous price target of $150 .Company shares were Reiterated by Topeka Capital Markets on Mar 2, 2016 to “Buy”, Firm has raised the Price Target to $ 155 from a previous price target of $145 .
Thermo Fisher Scientific Inc. is a provider of analytical instruments equipment reagents and consumables software and services for research manufacturing analysis discovery and diagnostics. The company operates through four segments: Life Sciences Solutions provides reagents instruments and consumables used in biological and medical research discovery and production of new drugs and vaccines as well as diagnosis of disease; Analytical Instruments provides instruments consumables software and services that are used in the laboratory; Specialty Diagnostics offers diagnostic test kits reagents culture media instruments and associated products and Laboratory Products and Services offers self-manufactured and sourced products for the laboratory.